BlackRock Japan
ATYR icon

BlackRock Japan’s aTyr Pharma ATYR Stock Holding History

BlackRock Japan’s Portfolio ATYR Stock Details ATYR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$7K Sell
230
-14
-6% -$574 ﹤0.01% 1244
2016
Q3 		$11K Sell
244
-21
-8% -$907 ﹤0.01% 1193
2016
Q2 		$10K Buy
265
+224
+546% +$10.4K ﹤0.01% 1283
2016
Q1 		$2K Buy
+41
New +$3.12K ﹤0.01% 1403

Other funds holding ATYR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
PVMCV
Polaris Venture Management Co V Boston, Massachusetts $14.1M AUM 121.41% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock Institutional Trust
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
BlackRock Advisors
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return
GHCM
Glen Harbor Capital Management San Diego, California $4.82B AUM 4.69% 1-Year Est. Return

BlackRock Japan's ATYR Position: Q4 2016 in Review

BlackRock Japan reduced its aTyr Pharma (ATYR) stake by 5.7% in Q4 2016, selling an estimated $574 and leaving 230 shares worth $7K. The position accounts for ﹤0.01% of the portfolio, ranked #1244.

BlackRock Japan first reported a position in ATYR in Q1 2016 and has held it in 4 quarters since. The position peaked at $11K in Q3 2016. 52 funds tracked by Wall St. Rank hold ATYR as of Q4 2016.

  • BlackRock Japan held 230 shares of aTyr Pharma worth $7K as of Q4 2016.
  • BlackRock Japan sold 14 aTyr Pharma shares in Q4 2016, an estimated $574.
  • aTyr Pharma made up ﹤0.01% of BlackRock Japan's portfolio in Q4 2016, its #1244 holding.
  • BlackRock Japan first reported a position in aTyr Pharma in Q1 2016 and has held it in 4 quarters since.
  • BlackRock Japan's aTyr Pharma position peaked at $11K in Q3 2016.
  • 52 funds tracked by Wall St. Rank held aTyr Pharma as of Q4 2016.

Based on BlackRock Japan's 13F filing for Q4 2016, filed 10 Feb 2017.